| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | Medicines Development for Global Health (MDGH) develops medicines and vaccines for neglected diseases. Our approach is to bring together the ideas of researchers with our development expertise and passion to develop new products that will be life changing for millions. We are a not-for-profit pharmaceutical company - all funds in excess of expenses are devoted to this purpose. In June 2018 we received US FDA approval of moxidectin, the first new treatment for River Blindness in more than 30 years. Next we're turning our attention to seeing the benefit moxidectin might bring to other neglected tropical diseases and scabies. Read more at medicinesdevelopment.com Games to be changed. Much work to do. Sign up for our quarterly newsletter here: https://bit.ly/3mwzi0N |
| Category: | Hardware & devices, Health & biotech |
| URL: | http://www.medicinesdevelopment.com |
| Operational Status: | |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2005 |
| Address: | Level 1, 18 Kavanagh St, Southbank, Melbourne, VIC 3006, AU |
| State: | Victoria |
| Overseas Operations: | |
| X: | |
| Facebook: | |
| Linkedin: | https://linkedin.com/company/medicines-development |
| Founders: |
No items found
|
| Awards won: | |
